We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Issues Final Guidances on 510(k) Refuse-to-Accept, PMA Review Policies
U.S. FDA Issues Final Guidances on 510(k) Refuse-to-Accept, PMA Review Policies
February 5, 2013
U.S. Food and Drug Administration (FDA) reviewers evaluating completeness of 510(k) submissions should consider only the presence of required information, and not whether it appears to be adequate, according to a final guidance on the agency’s 510(k) refuse-to-accept policy.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor